Project Number 5P50AG016574-14 Agency/Funding Organization NIA Funding Year 2012 View Full Project Details for THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATION Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 5. Other Proteinopathies b. TDP-43 and FUS Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator RADEMAKERS, ROSA Principal Investigator First Name ROSA Principal Investigator Last Name RADEMAKERS Awardee Organization MAYO CLINIC ROCHESTER Awardee State Minnesota Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-09-001: ALZHEIMER'S DISEASE RESEARCH CENTERS (P50) FY Overall Cost $170,851 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official SILVERBERG, NINA B Related Resources Repository National Alzheimer's Coordinating Center (NACC) National Alzheimer's Coordinating Center (NACC) [AlzPED] Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice. [AlzPED] Intracranial Adeno-Associated Virus-Mediated Delivery of Anti-Pan Amyloid β, Amyloid β40, and Amyloid β42 Single-Chain Variable Fragments Attenuates Plaque Pathology in Amyloid Precursor Protein Mice Clinical Trial Tau PET Imaging in African Americans ''Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies'' Pagination Previous page ‹‹ Page 2
